Form 4: Processa Pharmaceuticals CFO Receives Stock Grant
Insider Transaction (Form 4)
Russell Skibsted, Chief Financial Officer of Processa Pharmaceuticals, Inc., received 11,883 shares of common stock on July 26, 2026.
Summary
- Grant/award: acquired 11,883 Restricted Stock Units on July 26, 2026; holds 17,323 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Russell Skibsted — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-26 | Grant/award | Restricted Stock Units | 11,883 | — | — | 17,323 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-26 | Grant/award (11,883 shares) |
Keywords
insider transaction, Form 4, PCSA, Processa Pharmaceuticals, Inc., neutral, Russell Skibsted
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.